AceView: Gene:TGFBRAP1, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView.

cDNA accession Links to the sequence	Tissue most 5' clones in red	Match mRNA	From bp to bp in mRNA	From bp to bp in accs.	Clone encodes complete protein (with AA variation)	Features	Anomalies detected by AceView	Accession match over (% length)	Base differences relative to genome (% identity)
AA304990	colon	.b	4489 to 4852	1 to 364				364/364 (100 %)	0 diff (100 %id)
AA318935	adrenal gland	.b	4087 to 4394	1 to 310				310/310 (100 %)	2 diff (99.4 %id)
AA371409	Prostate	.b	5047 to 5322	1 to 274				274/274 (100 %)	2 diff (99.3 %id)
AF022795		.a	91 to 2953	25 to 2859		tiling clone,		2839/2859 (99 %)	8 diff (99.8 %id)
AK021697	whole embryo, mainly head	.b	1260 to 3305	1 to 2016		available from FLJ,		2018/2016 (100 %)	6 diff (99.8 %id)
AK025947		.b	4539 to 5999	1 to 1461		available from FLJ, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	1461/1461 (100 %)	2 diff (99.9 %id)
AK291382	brain	.b	362 to 3021	11 to 2669	L805S	tiling clone,		2659/2669 (99 %)	9 diff (99.7 %id)
AW367384	head_neck	.b	3269 to 3776	508 to 4		tiling clone,		505/508 (99 %)	0 diff (100 %id)
AW379448	head_neck	.b	1052 to 1227	181 to 6				176/199 (88 %)	2 diff (99.0 %id)
AW601940	breast	.b	5161 to 5535	379 to 5				375/379 (98 %)	0 diff (100 %id)
AW850414	colon	.c-u	4 to 440	1 to 437		tiling clone,		437/437 (100 %)	0 diff (100 %id)
AW957398		.b	5085 to 5563	1 to 482				482/483 (99 %)	27 diff (94.5 %id)
AW973855		.b	3202 to 3304	103 to 1			Submitted on the opposite strand	388/388 (100 %)	10 diff (97.5 %id)
BC020548	Lymph, lymphoma	.a	44 to 2989	1 to 2946		tiling clone, available from MGC, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	2946/2946 (100 %)	3 diff (99.9 %id)
BE143777	head_neck	.c-u	4 to 563	7 to 566		tiling clone,		560/566 (98 %)	12 diff (97.9 %id)
BE143822	head_neck	.c-u	1 to 469	1 to 468		tiling clone,		468/468 (100 %)	8 diff (98.3 %id)
BF155977	head_neck	.b	3225 to 3683	8 to 463		tiling clone,		456/463 (98 %)	6 diff (98.8 %id)
BF366664	nervous_tumor	.b	1328 to 1442	115 to 1				115/115 (100 %)	3 diff (97.4 %id)
BF373303	prostate_tumor	.b	2637 to 2854	1 to 219				219/219 (100 %)	3 diff (98.7 %id)
BF742848	breast	.b	4358 to 4736	1 to 378				378/378 (100 %)	2 diff (99.5 %id)
BF923155	nervous_tumor	.b	1820 to 2231	419 to 14			Submitted on the opposite strand	406/419 (96 %)	3 diff (99.3 %id)
BF932715	nervous_tumor	.b	2110 to 2466	365 to 9			Submitted on the opposite strand	357/365 (97 %)	0 diff (100 %id)
BG005720	placenta_normal	.b	712 to 1005	307 to 14				294/309 (95 %)	0 diff (100 %id)
BI715193	Pancreas, Purified pancreatic islet	.b	1679 to 2299	16 to 636				621/636 (97 %)	6 diff (99.1 %id)
BI792396	Pancreas, Purified pancreatic islet	.b	2699 to 3304	580 to 1				580/580 (100 %)	12 diff (98.0 %id)
AV755269	bone marrow	.b	4274 to 4673	72 to 471				400/733 (54 %)	2 diff (99.8 %id)
DA204670	brain	.b	4300 to 4880	2 to 582		capped		581/581 (100 %)	0 diff (100 %id)
DA242317	brain	.b	1977 to 2559	2 to 584		capped		583/583 (100 %)	1 diff (99.9 %id)
DA256245	caudate nucleus	.b	1506 to 2056	2 to 552		capped		551/551 (100 %)	1 diff (99.9 %id)
DA304749	hippocampus	.c-u	450 to 1030	2 to 583		tiling clone, capped		582/582 (100 %)	2 diff (99.7 %id)
DA310160	hippocampus	.b	844 to 1431	2 to 589		capped		588/588 (100 %)	0 diff (100 %id)
BX099060	liver and spleen	.b	3758 to 4469	1 to 714				714/714 (100 %)	4 diff (99.5 %id)
BX115619	breast	.b	2334 to 3073	1 to 740				740/740 (100 %)	0 diff (100 %id)
C02496		.b	5498 to 5817	1 to 320				320/322 (99 %)	1 diff (99.7 %id)
CN283066	embryonic stem cells, cell lines H1, H7, andH9	.b	3921 to 4469	17 to 564				548/564 (97 %)	6 diff (99.0 %id)
CN387714	embryonic stem cells, cell lines H1, H7, andH9	.b	2045 to 2673	21 to 649				629/649 (96 %)	6 diff (99.1 %id)
CN387715	embryonic stem cells, DMSO-treated H9 cellline	.b	1708 to 2198	1 to 491				491/491 (100 %)	5 diff (99.0 %id)
CN387716	embryonic stem cells, DMSO-treated H9 cellline	.b	2855 to 3346	1 to 492				492/494 (99 %)	5 diff (99.0 %id)
AL535848	brain, fetal brain	.a	91 to 921	1 to 831				831/831 (100 %)	6 diff (99.3 %id)
BX451450	brain, fetal brain	.b	1117 to 1942	11 to 836				826/876 (94 %)	16 diff (98.2 %id)
BX451451	brain, fetal brain	.b	1112 to 2019	3 to 906				904/906 (99 %)	11 diff (98.8 %id)
BX419237	brain, fetal brain	.c-u	1391 to 1666	432 to 707		tiling clone,		707/975 (72 %)	16 diff (98.4 %id)
BX455072	brain, fetal brain	.c-u	2102 to 2859	757 to 1		tiling clone,		757/903 (83 %)	17 diff (98.2 %id)
CA394377	eye, RPE/choroid	.b	4634 to 5266	1 to 633		tiling clone,		633/633 (100 %)	1 diff (99.9 %id)
CU457197	epidermis	.b	1547 to 2097	561 to 11			Submitted on the opposite strand	551/561 (98 %)	2 diff (99.7 %id)
CV023960	mixed	.b	425 to 974	1 to 553				553/553 (100 %)	13 diff (97.7 %id)
AL134300	brain	.b	892 to 1222	1 to 331				331/331 (100 %)	0 diff (100 %id)
BX477645		.b	4150 to 4665	1 to 516				516/516 (100 %)	0 diff (100 %id)
AL702943	human skeletal muscle	.b	2955 to 3352	1 to 399				399/399 (100 %)	1 diff (99.8 %id)
AL711746	human skeletal muscle	.b	1466 to 2083	1 to 617				617/617 (100 %)	8 diff (98.8 %id)
AL121441	melanoma (MeWo cell line)	.b	2393 to 2636	1 to 244				244/244 (100 %)	5 diff (98.0 %id)
AL135022	melanoma (MeWo cell line)	.b	4349 to 4665	1 to 317		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	317/317 (100 %)	0 diff (100 %id)
DW411747	Liver	.b	3202 to 3318	166 to 282				269/327 (82 %)	8 diff (97.6 %id)
DW449122	Liver	.b	3022 to 3199	21 to 198				178/202 (88 %)	4 diff (98.1 %id)
EC529108	Prostate	.b	2806 to 2911	1 to 106				106/106 (100 %)	5 diff (95.3 %id)
EL951640	eyeball	.b	5062 to 5581	1 to 520				520/520 (100 %)	8 diff (98.5 %id)
DA536876	heart	.b	3893 to 4450	2 to 559		capped		558/558 (100 %)	1 diff (99.9 %id)
DA539670	Kidney	.b	3883 to 4470	2 to 590		capped		589/589 (100 %)	1 diff (99.9 %id)
FN083596	breast carcinoma	.b	5582 to 5644	1 to 62				62/63 (98 %)	2 diff (96.9 %id)
GD143779		.b	4589 to 4671	1 to 83		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	83/83 (100 %)	4 diff (95.2 %id)
GD148288		.b	5784 to 5930	1 to 147		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	147/147 (100 %)	6 diff (96.0 %id)
BQ640068	eye, retina	.b	2264 to 2873	1 to 610				610/610 (100 %)	1 diff (99.9 %id)
AU118757	whole embryo, mainly head	.b	1261 to 2125	2 to 866		capped		865/865 (100 %)	9 diff (99.0 %id)
AU145246	whole embryo, mainly head	.b	2704 to 3305	570 to 1				570/570 (100 %)	17 diff (97.1 %id)
T47324	placenta	.b	4872 to 5180	1 to 312				312/314 (99 %)	5 diff (98.5 %id)
T47325	placenta	.b	5611 to 5933	325 to 1				325/325 (100 %)	4 diff (98.8 %id)
H22171	breast	.b	3202 to 3270	69 to 1				361/362 (99 %)	11 diff (97.0 %id)
H78571	liver and spleen	.b	4326 to 4676	356 to 3				354/356 (99 %)	0 diff (100 %id)
H78621	liver and spleen	.b	3759 to 4176	1 to 424				424/425 (99 %)	11 diff (97.5 %id)
H52225	ovarian tumor, ovary	.b	4185 to 4670	500 to 10				491/503 (97 %)	0 diff (100 %id)
H52316	ovarian tumor, ovary	.b	3918 to 4089	1 to 172				172/172 (100 %)	1 diff (99.5 %id)
AA701586	liver and spleen	.b	2817 to 3305	461 to 1				461/461 (100 %)	0 diff (100 %id)
AA777843	liver and spleen	.b	3202 to 3304	103 to 1				390/390 (100 %)	0 diff (100 %id)
AA485398	lung	.b	4703 to 4866	164 to 1				164/164 (100 %)	0 diff (100 %id)
AA516382	colon	.b	3202 to 3307	106 to 1				281/281 (100 %)	0 diff (100 %id)
AA568227	colon, colon tumor RER+	.b	3202 to 3304	103 to 1				431/431 (100 %)	2 diff (99.6 %id)
AA728793	alveolar rhabdomyosarcoma	.b	3202 to 3312	111 to 1				366/366 (100 %)	0 diff (100 %id)
AA810898	germinal center B cell	.b	3202 to 3315	114 to 1				442/442 (100 %)	0 diff (100 %id)
AA829477	germinal center B cell	.b	3202 to 3315	114 to 1				444/444 (100 %)	0 diff (100 %id)
AI140559	liver and spleen	.b	3202 to 3306	105 to 1				185/185 (100 %)	0 diff (100 %id)
AI033139	liver and spleen	.b	3202 to 3305	104 to 1				420/420 (100 %)	0 diff (100 %id)
AI086249	liver and spleen	.b	3225 to 3305	81 to 1				81/81 (100 %)	0 diff (100 %id)
AI034065	liver and spleen	.b	4246 to 4675	430 to 1				430/430 (100 %)	0 diff (100 %id)
AI076679	liver and spleen	.b	3202 to 3308	107 to 1				298/298 (100 %)	13 diff (95.7 %id)
AI092512	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.b	4129 to 4672	544 to 1				544/544 (100 %)	1 diff (99.9 %id)
AI092827	heart	.b	4227 to 4664	438 to 1				438/438 (100 %)	3 diff (99.4 %id)
AI090122	uterus	.b	4228 to 4672	445 to 1				445/445 (100 %)	0 diff (100 %id)
AI199831	placenta	.c-u	607 to 993	387 to 1				387/387 (100 %)	1 diff (99.8 %id)
AI222340	pooled	.b	4356 to 4665	313 to 4				310/313 (99 %)	0 diff (100 %id)
AI264042	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.b	4234 to 4675	442 to 1				442/442 (100 %)	1 diff (99.8 %id)
AI224487	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.b	4106 to 4675	564 to 1				564/602 (93 %)	17 diff (97.2 %id)
AI290870	carcinoid, lung	.b	4228 to 4785	562 to 5				558/562 (99 %)	0 diff (100 %id)
AI304844	carcinoid, lung	.b	2661 to 3315	627 to 1				627/627 (100 %)	7 diff (98.9 %id)
AI347965	adenocarcinoma, colon	.b	2797 to 3305	481 to 1				481/481 (100 %)	0 diff (100 %id)
AI334206	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.b	4486 to 4869	386 to 3				384/386 (99 %)	0 diff (100 %id)
AI393060	B-cell, chronic lymphotic leukemia	.b	4311 to 4672	399 to 37		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	363/363 (100 %)	3 diff (99.2 %id)
AI435349	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.b	5451 to 5975	525 to 1				525/525 (100 %)	0 diff (100 %id)
AI472815	pooled	.b	4383 to 4676	294 to 2				293/294 (99 %)	0 diff (100 %id)
AI458478	carcinoid, lung	.b	4245 to 4664	420 to 1				420/420 (100 %)	0 diff (100 %id)
AI458508	carcinoid, lung	.b	4305 to 4664	360 to 1				360/360 (100 %)	0 diff (100 %id)
AI457845	carcinoid, lung	.b	4227 to 4664	438 to 1				438/438 (100 %)	0 diff (100 %id)
AI570678	anaplastic oligodendroglioma, brain	.b	3202 to 3304	103 to 1				340/340 (100 %)	1 diff (99.8 %id)
AI640471	Kidney	.b	5642 to 5975	354 to 21		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	334/335 (99 %)	0 diff (100 %id)
AI915334	pooled	.b	4248 to 4676	430 to 1				430/434 (99 %)	3 diff (99.4 %id)
AI695108	colon	.b	3967 to 4499	1 to 531			Submitted on the opposite strand	531/531 (100 %)	37 diff (93.1 %id)
AI806639	pooled	.b	330 to 905	1 to 575			Submitted on the opposite strand	575/580 (99 %)	19 diff (96.8 %id)
AI932616	adenocarcinoma, Pancreas	.b	5510 to 5841	321 to 1				321/321 (100 %)	10 diff (96.9 %id)
AI936303	normal prostate, Prostate	.b	4218 to 4679	477 to 16				462/477 (96 %)	0 diff (100 %id)
AI955083	pooled germ cell tumors	.b	4421 to 4668	263 to 16		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	248/248 (100 %)	1 diff (99.6 %id)
AW000731	Prostate	.b	4449 to 4679	246 to 16				231/246 (93 %)	0 diff (100 %id)
AI978832	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	.b	5460 to 5841	382 to 1				382/382 (100 %)	0 diff (100 %id)
AI985503	Kidney	.b	5575 to 5933	360 to 2				359/360 (99 %)	0 diff (100 %id)
AW057971	thymus, pooled	.b	3965 to 4394	1 to 430			Submitted on the opposite strand	430/430 (100 %)	3 diff (99.4 %id)
AW071097	thymus, pooled	.b	4201 to 4676	478 to 3				476/478 (99 %)	0 diff (100 %id)
AW074418	colon, juvenile granulosa tumor	.b	3202 to 3305	104 to 1				299/299 (100 %)	4 diff (98.7 %id)
AW087615	pooled	.b	427 to 645	1 to 219			Submitted on the opposite strand	219/220 (99 %)	7 diff (96.9 %id)
AW194020	serous papillary carcinoma, high grade, 2pooled tumors, uterus	.b	3202 to 3305	104 to 1				447/447 (100 %)	0 diff (100 %id)
AW237600	Kidney	.b	5587 to 6030	443 to 2		tiling clone,		442/443 (99 %)	0 diff (100 %id)
AW207872		.b	4209 to 4661	471 to 20				452/471 (95 %)	0 diff (100 %id)
AW270978	Kidney	.b	4231 to 4672	457 to 16		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	442/442 (100 %)	2 diff (99.6 %id)
AW613926	pooled germ cell tumors	.b	4325 to 4679	356 to 2				355/356 (99 %)	0 diff (100 %id)
AW613940	pooled germ cell tumors	.b	4345 to 4679	337 to 2				336/337 (99 %)	0 diff (100 %id)
AW772699	normal epithelium, thyroid	.b	5631 to 5842	12 to 223			Submitted on the opposite strand	212/223 (95 %)	6 diff (97.4 %id)
BU430479	lymph	.b	359 to 873	1 to 515				515/515 (100 %)	9 diff (98.3 %id)
BF516373		.b	5387 to 5815	11 to 439			Submitted on the opposite strand	429/449 (95 %)	3 diff (99.4 %id)
CF142918	lymph	.b	3669 to 4047	8 to 386				379/386 (98 %)	6 diff (98.5 %id)
CF143723	lymph	.b	3669 to 4075	8 to 414				407/414 (98 %)	6 diff (98.6 %id)
BE672664	carcinoid, lung	.b	5225 to 5758	1 to 534			Submitted on the opposite strand	534/534 (100 %)	1 diff (99.9 %id)
BF002079	colon, colon tumor, RER+	.b	4367 to 4866	501 to 1				501/501 (100 %)	2 diff (99.7 %id)
BE999954	colon, colon tumor, RER+	.b	5503 to 5933	431 to 1				431/431 (100 %)	2 diff (99.6 %id)
BC010093	Eye, retinoblastoma	.b	354 to 2236	10 to 1892		tiling clone, AAA		1883/2321 (81 %)	1 diff (100.0 %id)
BC011136	Placenta, choriocarcinoma	.b	4261 to 4677	1 to 417		available from MGC, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	417/417 (100 %)	0 diff (100 %id)
BE538232	cervix	.b	4281 to 4677	1 to 395		available from MGC, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	395/395 (100 %)	2 diff (99.5 %id)
BF197588	Kidney	.b	5776 to 5933	167 to 10				158/167 (94 %)	0 diff (100 %id)
BE867160	adenocarcinoma, colon	.b	3619 to 4334	1 to 708				708/713 (99 %)	17 diff (97.7 %id)
BE787126	large cell carcinoma, lung	.b	3426 to 4075	1 to 649				649/649 (100 %)	4 diff (99.4 %id)
BE620966	epithelioid carcinoma, Pancreas	.b	3883 to 4228	1 to 347				347/348 (99 %)	4 diff (98.9 %id)
BE889417	leiomyosarcoma, uterus	.b	2110 to 2823	1 to 715				715/807 (88 %)	19 diff (97.7 %id)
BE894890	melanotic melanoma, skin	.b	4585 to 5208	1 to 624				624/629 (99 %)	3 diff (99.6 %id)
BG030587	breast, mammary adenocarcinoma, cell line	.b	4458 to 5236	1 to 775				775/969 (79 %)	20 diff (98.0 %id)
BG032686	breast, mammary adenocarcinoma, cell line	.b	2075 to 2820	1 to 736				736/745 (98 %)	12 diff (98.4 %id)
BG030857	breast, mammary adenocarcinoma, cell line	.b	2281 to 3061	1 to 777				777/1076 (72 %)	15 diff (98.7 %id)
BG115663	duodenal adenocarcinoma, cell line, small intestine	.b	2059 to 2779	1 to 718				718/1044 (68 %)	28 diff (97.4 %id)
BG177189	lymph, lymphoma, cell line	.a	36 to 795	5 to 776				772/1060 (72 %)	30 diff (97.2 %id)
BG169791	hypernephroma, cell line, Kidney	.b	1973 to 2776	1 to 790				790/795 (99 %)	44 diff (94.5 %id)
BC019841	Bladder, transitional cell papilloma	.b	4157 to 5999	1 to 1843		tiling clone, available from MGC, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	1843/1843 (100 %)	1 diff (100.0 %id)
BG289480	bladder, transitional cell papilloma, cell line	.b	4158 to 4928	1 to 767		available from MGC,		767/961 (79 %)	34 diff (96.5 %id)
BG385667	adenocarcinoma cell line, colon	.b	1903 to 2631	1 to 716				716/931 (76 %)	23 diff (97.6 %id)
BG828430	muscle, rhabdomyosarcoma	.b	1072 to 1729	1 to 654				654/654 (100 %)	11 diff (98.4 %id)
BI223766	cervical carcinoma cell line, cervix	.b	1380 to 1986	1 to 610				610/610 (100 %)	9 diff (98.6 %id)
BI756445	brain	.b	347 to 1090	1 to 744				744/744 (100 %)	3 diff (99.6 %id)
BI857196	breast, mammary adenocarcinoma, cell line	.b	5265 to 5933	1 to 666				666/701 (95 %)	8 diff (98.9 %id)
BI857114	breast, mammary adenocarcinoma, cell line	.b	5265 to 5933	1 to 668		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	668/668 (100 %)	1 diff (99.9 %id)
BI861119	breast, mammary adenocarcinoma, cell line	.b	3645 to 4481	1 to 829				829/834 (99 %)	14 diff (98.4 %id)
BI871623	adenocarcinoma, cell line, Liver	.b	3786 to 4526	1 to 741				741/741 (100 %)	5 diff (99.4 %id)
BM013421	brain, neuroblastoma, cell line	.b	3636 to 4527	1 to 894				894/894 (100 %)	19 diff (97.9 %id)
BM457015	embryonal carcinoma, cell line, testis	.b	3459 to 4333	1 to 892		tiling clone,		892/1034 (86 %)	21 diff (98.0 %id)
BM457417	embryonal carcinoma, cell line, testis	.b	1314 to 2234	1 to 932				932/1083 (86 %)	16 diff (98.6 %id)
BM545841	ovary (pool of 3)	.a	1 to 685	117 to 806				690/1132 (60 %)	25 diff (97.8 %id)
BM141729	Islets of Langerhans, Pancreas	.b	2750 to 3304	555 to 1		fully sequenced,		555/555 (100 %)	0 diff (100 %id)
BM142000	Islets of Langerhans, Pancreas	.b	2237 to 2780	1 to 544		fully sequenced,		544/544 (100 %)	0 diff (100 %id)
BQ269991	Pancreas, Purified pancreatic islet	.b	5257 to 5624	1 to 368		fully sequenced,		368/368 (100 %)	4 diff (99.0 %id)
BQ286648	Pancreas, Purified pancreatic islet	.b	5594 to 5976	383 to 1		fully sequenced,		383/383 (100 %)	2 diff (99.5 %id)
BQ021386	lung, Metastatic Chondrosarcoma	.b	4019 to 4663	658 to 15		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	644/644 (100 %)	1 diff (99.9 %id)
BQ013999	Chondrosarcoma, Left Pubic Bone	.b	2592 to 3305	704 to 19		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	686/686 (100 %)	3 diff (99.6 %id)
BM991047	lung, Lung Focal Fibrosis	.b	5207 to 5818	1 to 612			Submitted on the opposite strand	612/612 (100 %)	16 diff (97.4 %id)
BQ001673	lung, Metastatic Chondrosarcoma	.b	4012 to 4663	666 to 15		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	652/652 (100 %)	0 diff (100 %id)
BQ053895	blood, natural killer cells, cell line	.b	2236 to 3089	1 to 861				861/1068 (80 %)	13 diff (98.8 %id)
BQ777312	Pancreas, Purified pancreatic islet	.b	1683 to 2305	1 to 623				623/623 (100 %)	1 diff (99.9 %id)
BQ788001	Pancreas, Purified pancreatic islet	.b	2677 to 3304	600 to 1				600/600 (100 %)	1 diff (99.9 %id)
BQ777344	Pancreas, Purified pancreatic islet	.b	1430 to 1901	11 to 482				472/482 (97 %)	6 diff (98.8 %id)
BQ788029	Pancreas, Purified pancreatic islet	.b	2651 to 3304	626 to 1				626/626 (100 %)	0 diff (100 %id)
BU153976	eye, retinoblastoma	.b	4453 to 5251	1 to 808				808/824 (98 %)	14 diff (98.4 %id)
BU176010	eye, retinoblastoma	.b	2166 to 3019	1 to 867				865/891 (97 %)	13 diff (98.6 %id)
BQ424023	eye, retinoblastoma	.b	3202 to 3305	129 to 232		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	232/232 (100 %)	0 diff (100 %id)
BU182695	melanotic melanoma, skin	.b	3202 to 3305	257 to 359		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	359/359 (100 %)	1 diff (99.8 %id)
BQ672362	epidermoid carcinoma, cell line, salivary gland	.b	4822 to 5718	1 to 898				898/900 (99 %)	10 diff (98.9 %id)
BQ936067	large cell carcinoma, lung	.b	93 to 645	100 to 660				561/1105 (50 %)	29 diff (97.4 %id)
BQ941746	large cell carcinoma, lung	.b	1 to 896	22 to 920		tiling clone,		899/961 (93 %)	29 diff (97.0 %id)
BU933042	mixed (pool of 40 RNAs)	.b	5254 to 6029	1 to 775				775/783 (98 %)	16 diff (98.0 %id)
BU941276	mixed (pool of 40 RNAs)	.b	4722 to 5368	1 to 656				656/933 (70 %)	40 diff (95.8 %id)
CX788961	human embryonic stem cells	.b	3960 to 4675	9 to 722		tiling clone,		714/722 (98 %)	6 diff (99.2 %id)
CX752573	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.b	2749 to 3354	1 to 606		tiling clone,	Submitted on the opposite strand	606/606 (100 %)	0 diff (100 %id)
DR760184	embryonic stem	.b	3202 to 3355	45 to 198				198/198 (100 %)	0 diff (100 %id)
CB961685	placenta, pre-eclamptic placenta	.a	2 to 714	28 to 744		tiling clone,		717/803 (89 %)	14 diff (98.3 %id)
CD245374	White Matter	.b	1473 to 2372	26 to 936				888/937 (94 %)	25 diff (97.4 %id)
CD514546	White Matter	.b	4450 to 5224	11 to 790				780/902 (86 %)	6 diff (99.4 %id)
CF144162	lymph	.b	3669 to 3993	8 to 332				325/332 (97 %)	6 diff (98.2 %id)
CF596029	Stomach, adenocarcinoma	.b	4413 to 4954	1 to 549				549/737 (74 %)	15 diff (98.0 %id)
DA618766		.b	663 to 1167	2 to 506		capped		505/505 (100 %)	1 diff (99.9 %id)
TI_57220292		.b	347 to 1090	32 to 775				744/775 (96 %)	9 diff (98.9 %id)
TI_57186768		.b	5265 to 5933	54 to 721		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	668/668 (100 %)	1 diff (99.9 %id)
TI_57186860		.b	5265 to 5933	56 to 721				666/948 (70 %)	8 diff (99.2 %id)
TI_57192881		.b	3645 to 4481	55 to 883				829/834 (99 %)	14 diff (98.4 %id)
TI_57230762		.b	3786 to 4526	56 to 796				741/741 (100 %)	5 diff (99.4 %id)
TI_59380241		.b	3637 to 4527	96 to 988				893/893 (100 %)	18 diff (98.0 %id)
CB114590	Liver	.b	3202 to 3356	24 to 175				175/175 (100 %)	1 diff (99.5 %id)
NM_004257.4		.a	25 to 2989	1 to 2965		RefSeq, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	2965/2965 (100 %)	0 diff (100 %id)
NM_001142621.1		.b	344 to 3305	1 to 2962		RefSeq, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	2962/2962 (100 %)	0 diff (100 %id)
DA804975	brain	.b	2176 to 2679	2 to 509		capped		508/508 (100 %)	4 diff (99.3 %id)
DA810614	brain	.b	2159 to 2703	2 to 546		capped		545/545 (100 %)	0 diff (100 %id)
BP328460	rectum	.b	1917 to 2498	1 to 582				582/582 (100 %)	0 diff (100 %id)
CT002669	T-Lymphocytes	.b	449 to 1219	1 to 772				772/773 (99 %)	6 diff (99.3 %id)
TI_1948081794		.b	418 to 1064	117 to 761				645/1117 (57 %)	28 diff (97.5 %id)
TI_1948081796		.b	2088 to 3014	1045 to 125				921/1151 (80 %)	23 diff (98.1 %id)
TI_1948082018		.b	2250 to 3014	846 to 82				765/1078 (70 %)	28 diff (97.5 %id)
TI_1948082226		.b	2709 to 3013	424 to 121				304/1129 (26 %)	3 diff (99.8 %id)
TI_1948082453		.b	418 to 1060	115 to 760				646/1139 (56 %)	33 diff (97.2 %id)
TI_1948082454		.b	418 to 1190	121 to 902				782/1375 (56 %)	26 diff (98.2 %id)
TI_1948082455		.b	2175 to 3014	953 to 126				828/1101 (75 %)	16 diff (98.6 %id)
DA913658		.b	2668 to 3135	2 to 469		capped		468/468 (100 %)	0 diff (100 %id)
DA946093	Spleen	.d-u	1 to 578	2 to 579	exact	tiling clone, capped		578/578 (100 %)	3 diff (99.5 %id)
T15625		.b	5638 to 6030	399 to 1				399/483 (82 %)	11 diff (97.8 %id)
T16844		.b	4650 to 4997	28 to 374				347/374 (92 %)	3 diff (99.2 %id)
DA999308	breast, tumor tissue	.b	3618 to 4150	2 to 536		capped		535/535 (100 %)	4 diff (99.3 %id)
DN993139	brain, whole brain	.b	4213 to 4807	9 to 603				595/603 (98 %)	6 diff (99.1 %id)
DN995868	breast cancer, Mammary gland (cancer tissue)	.a	91 to 677	39 to 625				587/625 (93 %)	6 diff (99.1 %id)
DB150781	thymus	.b	357 to 899	2 to 545		capped		544/544 (100 %)	1 diff (99.9 %id)
DB151659	thymus	.b	3202 to 3341	277 to 417		capped		416/416 (100 %)	1 diff (99.8 %id)
TI_154022742		.b	5071 to 5782	84 to 796			Submitted on the opposite strand	713/796 (89 %)	7 diff (99.2 %id)
TI_154037241		.b	4008 to 4663	746 to 74		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	673/826 (81 %)	41 diff (95.1 %id)
TI_154115480		.b	2396 to 3305	953 to 84		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	870/976 (89 %)	18 diff (98.2 %id)
TI_154151867		.b	364 to 1046	78 to 757				680/680 (100 %)	22 diff (96.8 %id)
TI_154174158		.b	3669 to 4111	86 to 528				443/1123 (39 %)	8 diff (99.3 %id)
TI_154175310		.b	3669 to 4102	92 to 528				437/1193 (36 %)	10 diff (99.2 %id)
TI_159713763		.b	2381 to 3305	973 to 85		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	889/1040 (85 %)	22 diff (97.9 %id)
CB851910	Human Lung Epithelial cells, lung	.b	2599 to 3305	697 to 19		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	679/681 (99 %)	0 diff (100 %id)
BM663447	eye, RPE and Choroid	.b	2803 to 3305	492 to 18		fully sequenced, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	475/475 (100 %)	9 diff (98.2 %id)
BM685537	eye, RPE and Choroid	.b	2451 to 2861	9 to 415		fully sequenced,	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	407/415 (98 %)	6 diff (98.6 %id)
BM672953	eye, optic nerve	.b	5549 to 5975	445 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	427/427 (100 %)	2 diff (99.6 %id)
BM686771	eye, optic nerve	.b	5145 to 5579	1 to 436		fully sequenced,	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	436/436 (100 %)	7 diff (98.4 %id)
BM672475	eye, optic nerve	.b	4245 to 4665	439 to 19		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	421/421 (100 %)	0 diff (100 %id)
BM687328	eye, optic nerve	.b	3712 to 4130	9 to 427			Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	419/427 (98 %)	6 diff (98.6 %id)
BM722087	eye, fetal eye	.b	3202 to 3274	205 to 277				218/280 (77 %)	10 diff (96.5 %id)
BM676901	eye, fetal eye	.b	2734 to 3305	562 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	544/544 (100 %)	0 diff (100 %id)
BM720798	eye, fetal eye	.b	2226 to 2764	1 to 539		fully sequenced,	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	539/539 (100 %)	1 diff (99.9 %id)
CA439196	lung, Lung Focal Fibrosis	.b	5066 to 5752	1 to 688			Submitted on the opposite strand	688/688 (100 %)	9 diff (98.7 %id)
CA449205	Chondrosarcoma, Left Pubic Bone	.b	2543 to 3305	753 to 19		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	735/735 (100 %)	1 diff (99.9 %id)
DB275584	uterus	.b	1644 to 2189	2 to 547		capped		546/546 (100 %)	1 diff (99.9 %id)
BQ344996	nervous_tumor	.b	2651 to 3304	626 to 1			This clone was ignored	626/626 (100 %)	0 diff (100 %id)
DA567947		.b	4453 to 5251	1 to 808		capped	This clone was ignored	808/824 (98 %)	14 diff (98.4 %id)
DB318901		.b	4453 to 5251	1 to 808			This clone was ignored	808/824 (98 %)	14 diff (98.4 %id)
N21179	melanocyte	.b	2166 to 3019	1 to 867			This clone was ignored	865/891 (97 %)	13 diff (98.6 %id)
N29143	melanocyte	.b	2166 to 3019	1 to 867			This clone was ignored	865/891 (97 %)	13 diff (98.6 %id)
AV761881	bone marrow	.b	3202 to 3305	129 to 232			Suspected internal deletion, this clone was ignored	232/232 (100 %)	0 diff (100 %id)
DA781784	brain	.b	3202 to 3305	129 to 232		capped	Suspected internal deletion, this clone was ignored	232/232 (100 %)	0 diff (100 %id)
TI_159696492		.b	3202 to 3305	257 to 359			Suspected internal deletion, this clone was ignored	359/359 (100 %)	1 diff (99.8 %id)
BU182695	melanotic melanoma, skin	.b	3202 to 3305	257 to 359		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	359/359 (100 %)	1 diff (99.8 %id)
BQ672362	epidermoid carcinoma, cell line, salivary gland	.b	4822 to 5718	1 to 898				898/900 (99 %)	10 diff (98.9 %id)
BQ672362	epidermoid carcinoma, cell line, salivary gland	.b	4822 to 5718	1 to 898				898/900 (99 %)	10 diff (98.9 %id)
BQ936067	large cell carcinoma, lung	.b	93 to 645	100 to 660				561/1105 (50 %)	29 diff (97.4 %id)
BQ936067	large cell carcinoma, lung	.b	93 to 645	100 to 660				561/1105 (50 %)	29 diff (97.4 %id)
BQ941746	large cell carcinoma, lung	.b	1 to 896	22 to 920		tiling clone,		899/961 (93 %)	29 diff (97.0 %id)
BQ941746	large cell carcinoma, lung	.b	1 to 896	22 to 920		tiling clone,		899/961 (93 %)	29 diff (97.0 %id)
BU933042	mixed (pool of 40 RNAs)	.b	5254 to 6029	1 to 775				775/783 (98 %)	16 diff (98.0 %id)
BU941276	mixed (pool of 40 RNAs)	.b	4722 to 5368	1 to 656				656/933 (70 %)	40 diff (95.8 %id)
CX788961	human embryonic stem cells	.b	3960 to 4675	9 to 722		tiling clone,		714/722 (98 %)	6 diff (99.2 %id)
CX752573	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.b	2749 to 3354	1 to 606		tiling clone,	Submitted on the opposite strand	606/606 (100 %)	0 diff (100 %id)
CX752573	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.b	2749 to 3354	1 to 606		tiling clone,	Submitted on the opposite strand	606/606 (100 %)	0 diff (100 %id)
DR760184	embryonic stem	.b	3202 to 3355	45 to 198				198/198 (100 %)	0 diff (100 %id)
CB961685	placenta, pre-eclamptic placenta	.a	2 to 714	28 to 744		tiling clone,		717/803 (89 %)	14 diff (98.3 %id)
CB961685	placenta, pre-eclamptic placenta	.a	2 to 714	28 to 744		tiling clone,		717/803 (89 %)	14 diff (98.3 %id)
CD245374	White Matter	.b	1473 to 2372	26 to 936				888/937 (94 %)	25 diff (97.4 %id)
CD514546	White Matter	.b	4450 to 5224	11 to 790				780/902 (86 %)	6 diff (99.4 %id)
CF144162	lymph	.b	3669 to 3993	8 to 332				325/332 (97 %)	6 diff (98.2 %id)
CF596029	Stomach, adenocarcinoma	.b	4413 to 4954	1 to 549				549/737 (74 %)	15 diff (98.0 %id)
DA618766		.b	663 to 1167	2 to 506		capped		505/505 (100 %)	1 diff (99.9 %id)
TI_57220292		.b	347 to 1090	32 to 775				744/775 (96 %)	9 diff (98.9 %id)
TI_57186768		.b	5265 to 5933	54 to 721		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	668/668 (100 %)	1 diff (99.9 %id)
TI_57186860		.b	5265 to 5933	56 to 721				666/948 (70 %)	8 diff (99.2 %id)
TI_57192881		.b	3645 to 4481	55 to 883				829/834 (99 %)	14 diff (98.4 %id)
TI_57230762		.b	3786 to 4526	56 to 796				741/741 (100 %)	5 diff (99.4 %id)
TI_59380241		.b	3637 to 4527	96 to 988				893/893 (100 %)	18 diff (98.0 %id)
CB114590	Liver	.b	3202 to 3356	24 to 175				175/175 (100 %)	1 diff (99.5 %id)
NM_004257.4		.a	25 to 2989	1 to 2965		RefSeq, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	2965/2965 (100 %)	0 diff (100 %id)
NM_001142621.1		.b	344 to 3305	1 to 2962		RefSeq, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	2962/2962 (100 %)	0 diff (100 %id)
DA804975	brain	.b	2176 to 2679	2 to 509		capped		508/508 (100 %)	4 diff (99.3 %id)
DA810614	brain	.b	2159 to 2703	2 to 546		capped		545/545 (100 %)	0 diff (100 %id)
BP328460	rectum	.b	1917 to 2498	1 to 582				582/582 (100 %)	0 diff (100 %id)
CT002669	T-Lymphocytes	.b	449 to 1219	1 to 772				772/773 (99 %)	6 diff (99.3 %id)
TI_1948081794		.b	418 to 1064	117 to 761				645/1117 (57 %)	28 diff (97.5 %id)
TI_1948081796		.b	2088 to 3014	1045 to 125				921/1151 (80 %)	23 diff (98.1 %id)
TI_1948082018		.b	2250 to 3014	846 to 82				765/1078 (70 %)	28 diff (97.5 %id)
TI_1948082226		.b	2709 to 3013	424 to 121				304/1129 (26 %)	3 diff (99.8 %id)
TI_1948082453		.b	418 to 1060	115 to 760				646/1139 (56 %)	33 diff (97.2 %id)
TI_1948082454		.b	418 to 1190	121 to 902				782/1375 (56 %)	26 diff (98.2 %id)
TI_1948082455		.b	2175 to 3014	953 to 126				828/1101 (75 %)	16 diff (98.6 %id)
DA913658		.b	2668 to 3135	2 to 469		capped		468/468 (100 %)	0 diff (100 %id)
DA946093	Spleen	.d-u	1 to 578	2 to 579	exact	tiling clone, capped		578/578 (100 %)	3 diff (99.5 %id)
T15625		.b	5638 to 6030	399 to 1				399/483 (82 %)	11 diff (97.8 %id)
T16844		.b	4650 to 4997	28 to 374				347/374 (92 %)	3 diff (99.2 %id)
DA999308	breast, tumor tissue	.b	3618 to 4150	2 to 536		capped		535/535 (100 %)	4 diff (99.3 %id)
DN993139	brain, whole brain	.b	4213 to 4807	9 to 603				595/603 (98 %)	6 diff (99.1 %id)
DN993139	brain, whole brain	.b	4213 to 4807	9 to 603				595/603 (98 %)	6 diff (99.1 %id)
DN995868	breast cancer, Mammary gland (cancer tissue)	.a	91 to 677	39 to 625				587/625 (93 %)	6 diff (99.1 %id)
DN995868	breast cancer, Mammary gland (cancer tissue)	.a	91 to 677	39 to 625				587/625 (93 %)	6 diff (99.1 %id)
DB150781	thymus	.b	357 to 899	2 to 545		capped		544/544 (100 %)	1 diff (99.9 %id)
DB151659	thymus	.b	3202 to 3341	277 to 417		capped		416/416 (100 %)	1 diff (99.8 %id)
TI_154022742		.b	5071 to 5782	84 to 796			Submitted on the opposite strand	713/796 (89 %)	7 diff (99.2 %id)
TI_154037241		.b	4008 to 4663	746 to 74		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	673/826 (81 %)	41 diff (95.1 %id)
TI_154115480		.b	2396 to 3305	953 to 84		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	870/976 (89 %)	18 diff (98.2 %id)
TI_154151867		.b	364 to 1046	78 to 757				680/680 (100 %)	22 diff (96.8 %id)
TI_154174158		.b	3669 to 4111	86 to 528				443/1123 (39 %)	8 diff (99.3 %id)
TI_154175310		.b	3669 to 4102	92 to 528				437/1193 (36 %)	10 diff (99.2 %id)
TI_159713763		.b	2381 to 3305	973 to 85		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	889/1040 (85 %)	22 diff (97.9 %id)
CB851910	Human Lung Epithelial cells, lung	.b	2599 to 3305	697 to 19		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	679/681 (99 %)	0 diff (100 %id)
CB851910	Human Lung Epithelial cells, lung	.b	2599 to 3305	697 to 19		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	679/681 (99 %)	0 diff (100 %id)
BM663447	eye, RPE and Choroid	.b	2803 to 3305	492 to 18		fully sequenced, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	475/475 (100 %)	9 diff (98.2 %id)
BM663447	eye, RPE and Choroid	.b	2803 to 3305	492 to 18		fully sequenced, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	475/475 (100 %)	9 diff (98.2 %id)
BM685537	eye, RPE and Choroid	.b	2451 to 2861	9 to 415		fully sequenced,	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	407/415 (98 %)	6 diff (98.6 %id)
BM685537	eye, RPE and Choroid	.b	2451 to 2861	9 to 415		fully sequenced,	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	407/415 (98 %)	6 diff (98.6 %id)
BM672953	eye, optic nerve	.b	5549 to 5975	445 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	427/427 (100 %)	2 diff (99.6 %id)
BM672953	eye, optic nerve	.b	5549 to 5975	445 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	427/427 (100 %)	2 diff (99.6 %id)
BM686771	eye, optic nerve	.b	5145 to 5579	1 to 436		fully sequenced,	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	436/436 (100 %)	7 diff (98.4 %id)
BM686771	eye, optic nerve	.b	5145 to 5579	1 to 436		fully sequenced,	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	436/436 (100 %)	7 diff (98.4 %id)
BM672475	eye, optic nerve	.b	4245 to 4665	439 to 19		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	421/421 (100 %)	0 diff (100 %id)
BM672475	eye, optic nerve	.b	4245 to 4665	439 to 19		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	421/421 (100 %)	0 diff (100 %id)
BM687328	eye, optic nerve	.b	3712 to 4130	9 to 427			Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	419/427 (98 %)	6 diff (98.6 %id)
BM687328	eye, optic nerve	.b	3712 to 4130	9 to 427			Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	419/427 (98 %)	6 diff (98.6 %id)
BM722087	eye, fetal eye	.b	3202 to 3274	205 to 277				218/280 (77 %)	10 diff (96.5 %id)
BM722087	eye, fetal eye	.b	3202 to 3274	205 to 277				218/280 (77 %)	10 diff (96.5 %id)
BM676901	eye, fetal eye	.b	2734 to 3305	562 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	544/544 (100 %)	0 diff (100 %id)
BM676901	eye, fetal eye	.b	2734 to 3305	562 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	544/544 (100 %)	0 diff (100 %id)
BM720798	eye, fetal eye	.b	2226 to 2764	1 to 539		fully sequenced,	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	539/539 (100 %)	1 diff (99.9 %id)
BM720798	eye, fetal eye	.b	2226 to 2764	1 to 539		fully sequenced,	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	539/539 (100 %)	1 diff (99.9 %id)
CA439196	lung, Lung Focal Fibrosis	.b	5066 to 5752	1 to 688			Submitted on the opposite strand	688/688 (100 %)	9 diff (98.7 %id)
CA439196	lung, Lung Focal Fibrosis	.b	5066 to 5752	1 to 688			Submitted on the opposite strand	688/688 (100 %)	9 diff (98.7 %id)
CA449205	Chondrosarcoma, Left Pubic Bone	.b	2543 to 3305	753 to 19		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	735/735 (100 %)	1 diff (99.9 %id)
CA449205	Chondrosarcoma, Left Pubic Bone	.b	2543 to 3305	753 to 19		AAA	Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base)	735/735 (100 %)	1 diff (99.9 %id)
DB275584	uterus	.b	1644 to 2189	2 to 547		capped		546/546 (100 %)	1 diff (99.9 %id)